Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognizes Phi...
Vienna-based Biotech Company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phön...
Medical Devices company, ResMed has announced that it has entered a definitive agreement to acquire Propeller Health, a ...
Pharma company, Domain Therapeutics has announced a multi-targetdrug discovery collaboration and licensing agreement wit...
argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...
Editas Medicine, a genome editing company has announced results from experiments to demonstrate expanded CRISPR genome e...
Auris Health, Inc. has announced the close of a $220 million equity financing led by Partner Fund Management. New invest...
Biocartis Group NV, an innovative molecular diagnostics company, has entered into an agreement with AstraZeneca, a globa...
The U.S. Food and Drug Administration has approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton m...
Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory dise...
GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SB...
Pharma company, Incyte has announced the appointment of Dashyant Dhanak as Executive Vice President and Chief Scientific...
US based pharma company Roivant Sciences and Cincinnati Children’s Hospital Medical centre has announced...
Frazier Healthcare Partners has announced Mimi Hancock, Ph.D. has joined its Life Sciences team as a Senior Advisor to a...
Receptor Life Sciences has announced the appointment of Orrin Devinsky, M.D., as the company’s Chief Medical Offic...
The World Health Organization (WHO) has launched a new community-driven platform - the Knowledge Action Portal (KAP) - f...
CURE Pharmaceutical, an innovative drug delivery and development company, has secured a new registration with the Drug E...
U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...
